Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, inherited or acquired syndrome characterized by the presence of histiocytes in the bone marrow which contain granules stained blue with hematoxylin-eosin stain, mild thrombocytopenia and purpura, and splenomegaly.
Features include always present findings: Elevated circulating aspartate aminotransferase concentration, Sea-blue histiocytosis, Foam cells, and Low platelet count (thrombocytopenia) and others. 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 2 | Elevated circulating aspartate aminotransferase concentration, Elevated circulating alanine aminotransferase concentration |
APOE encodes apolipoprotein E (317 aa). APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. Highest expression in Adrenal Gland (3,543 TPM) and Liver (3,182 TPM).
Sea-blue histiocyte syndrome is associated with mutations in the APOE gene on chromosome 19.
APOE is classified as a druggable target (Druggable Genome category) with score 0.9.
Genetic testing for APOE is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for sea-blue histiocyte syndrome has been reported in the published literature.
Phenotype severity distribution: 6 always present features.
No clinical trials have been registered for sea-blue histiocyte syndrome.
8 publications have been identified in PubMed for sea-blue histiocyte syndrome. Research spans Case Report / Case Series (88%) and Diagnostic / Biomarker (13%).
Liu W (2026). [PMID: 41791926](https://pubmed.ncbi.nlm.nih.gov/41791926/). *Journal of clinical lipidology*. [Case Report / Case Series]
Safatle-Ribeiro AV (2025). [PMID: 40148218](https://pubmed.ncbi.nlm.nih.gov/40148218/). *Endoscopy*. [Diagnostic / Biomarker]
Ferreira EA (2025). [PMID: 40149441](https://pubmed.ncbi.nlm.nih.gov/40149441/). *Genes*. [Case Report / Case Series]
Mrad S (2025). [PMID: 41879707](https://pubmed.ncbi.nlm.nih.gov/41879707/). *La Tunisie medicale*. [Case Report / Case Series]
Zambrano AK (2025). [PMID: 40779757](https://pubmed.ncbi.nlm.nih.gov/40779757/). *Medwave*. [Case Report / Case Series]
She QY (2024). [PMID: 39027568](https://pubmed.ncbi.nlm.nih.gov/39027568/). *Heliyon*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Digestive system |
2 |
Liver scarring (cirrhosis) (cirrhosis), Enlarged spleen (splenomegaly) |
Blood and immune system | 2 | Low platelet count (thrombocytopenia), Enlarged spleen (splenomegaly) |
Wang SH (2024). [PMID: 39357187](https://pubmed.ncbi.nlm.nih.gov/39357187/). *Pathology, research and practice*. [Case Report / Case Series]
Bourrienne MC (2024). [PMID: 38115676](https://pubmed.ncbi.nlm.nih.gov/38115676/). *American journal of hematology*. [Case Report / Case Series]